Immunohistochemical Expression

Immunohistochemistry (IHC) is an ancillary method, widely used in pathologists’ practice, that allows identifying diagnostic and prognostic/predictive of therapeutic response protein markers on tissue samples by the use of specific monoclonal antibodies and chromogenic substances that guarantee the...

Full description

Saved in:
Bibliographic Details
HerausgeberIn:
Sonstige:
Year of Publication:2021
Language:English
Physical Description:1 electronic resource (168 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 03626nam-a2200925z--4500
001 993545172604498
005 20231214132933.0
006 m o d
007 cr|mn|---annan
008 202201s2021 xx |||||o ||| 0|eng d
035 |a (CKB)5400000000042095 
035 |a (oapen)https://directory.doabooks.org/handle/20.500.12854/76432 
035 |a (EXLCZ)995400000000042095 
041 0 |a eng 
100 1 |a Caltabiano, Rosario  |4 edt 
245 1 0 |a Immunohistochemical Expression 
260 |a Basel, Switzerland  |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2021 
300 |a 1 electronic resource (168 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
520 |a Immunohistochemistry (IHC) is an ancillary method, widely used in pathologists’ practice, that allows identifying diagnostic and prognostic/predictive of therapeutic response protein markers on tissue samples by the use of specific monoclonal antibodies and chromogenic substances that guarantee the visualization of an antibody–antigene binding complex under a light microscope [1]. Coon et al., in 1941 [2], first introduced the use of fluorochrome-conjugated antibodies in clinical practice. Since then, IHC has gone from being a useful tool for identifying the differentiation line of otherwise undifferentiated cells to a technique capable of providing not only diagnostic but also prognostic and predictive indications of responses to specific therapeutic options [1,3]. The abovementioned peculiarities have made IHC one of the most used ancillary methods in the histopathological approach to human neoplastic and non-neoplastic diseases [3-5]. This Special Issue contains 11 accepted papers that provide readers with a comprehensive update on current and future applications of IHC in medical practice. 
546 |a English 
650 7 |a Medicine  |2 bicssc 
653 |a training exercise 
653 |a NGAL 
653 |a VDR 
653 |a kidney 
653 |a heart 
653 |a immunohistochemistry 
653 |a ABCB5 
653 |a uveal melanoma 
653 |a prognosis 
653 |a metastasis 
653 |a pericardium 
653 |a cytokeratin 
653 |a c-kit 
653 |a PDGFR 
653 |a initial lymphatics 
653 |a macroH2A 
653 |a prognostic factor 
653 |a SLC22A12 
653 |a URAT1 
653 |a hypouricemia 
653 |a uric acid transporters 
653 |a excretion fraction of uric acid 
653 |a Hsp27 
653 |a Hsp60 
653 |a Hsp70 
653 |a Hsp90 
653 |a molecular chaperone 
653 |a chaperonopathies 
653 |a thyroid 
653 |a follicular adenoma 
653 |a follicular carcinoma 
653 |a differential diagnosis 
653 |a carcinogenesis 
653 |a matrix metalloproteinases 
653 |a temporomandibular joint disorder 
653 |a temporomandibular joint 
653 |a DEN 
653 |a liver 
653 |a inflammation 
653 |a ultra-structural changes 
653 |a oxidative stress 
653 |a EGCG 
653 |a Vitamin D 
653 |a prostate cancer 
653 |a urinary tract malformations 
653 |a megacystis 
653 |a enteric nervous system 
653 |a outcome and prognosis 
653 |a WT1 
653 |a human embryonal/fetal tissues 
653 |a neoplastic tissue 
776 |z 3-0365-0400-1 
776 |z 3-0365-0401-X 
700 1 |a Loreto, Carla  |4 edt 
700 1 |a Caltabiano, Rosario  |4 oth 
700 1 |a Loreto, Carla  |4 oth 
906 |a BOOK 
ADM |b 2023-12-15 05:36:34 Europe/Vienna  |f system  |c marc21  |a 2022-04-04 09:22:53 Europe/Vienna  |g false 
AVE |i DOAB Directory of Open Access Books  |P DOAB Directory of Open Access Books  |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5337874300004498&Force_direct=true  |Z 5337874300004498  |b Available  |8 5337874300004498